Scroll for more
news Nov 8, 2016

Janssen licenses drugs to artificial intelligence company

CEO of BenevolentBio, Professor Jackie Hunter, gives her expert insight on the need for the drug discovery sector to be leaner, the uses of deep learning in drug discovery and a brief overview of her work at BenevolentAI.

Janssen licenses drugs to artificial intelligence company